Your browser doesn't support javascript.
loading
Protocol for high-throughput reservoir quantification across global HIV subtypes using a cross-subtype intact proviral DNA assay.
Fish, Carolyn S; Cassidy, Noah A J; Levy, Claire N; Hughes, Sean M; Jerome, Keith R; Overbaugh, Julie; Hladik, Florian; Lehman, Dara A.
Affiliation
  • Fish CS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Cassidy NAJ; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Levy CN; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.
  • Hughes SM; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.
  • Jerome KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 8109, USA.
  • Overbaugh J; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Hladik F; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98109, USA.
  • Lehman DA; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Global Health, University of Washington, Seattle, WA 98109, USA. Electronic address: dlehman@fredhutch.org.
STAR Protoc ; 3(4): 101681, 2022 12 16.
Article in En | MEDLINE | ID: mdl-36178789
ABSTRACT
The cross-subtype intact proviral DNA assay (CS-IPDA) is a high-throughput method to quantify HIV reservoir size in populations infected with any of the dominant global HIV-1 subtypes. Our protocol includes genomic DNA isolation optimized to minimize DNA shearing, a reference droplet digital PCR (ddPCR) assay to quantify T cells and assess DNA shearing, and a multiplex ddPCR targeting three distinct regions across the HIV genome to quantify intact proviruses as an estimate of replication-competent proviruses in the reservoir. For complete details on the use and execution of this protocol, please refer to Cassidy et al. (2022).
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 Limits: Humans Language: En Journal: STAR Protoc Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 Limits: Humans Language: En Journal: STAR Protoc Year: 2022 Document type: Article Affiliation country:
...